Published in Clin Sci (Lond) on July 01, 1993
Some effects of oral contraceptives on carbohydrate metabolism. Lancet (1966) 5.48
Cardiologists rebuked. Lancet (1994) 3.85
Potassium chloride and intestinal ulceration. Lancet (1965) 3.42
Comparison of effects of different combined oral-contraceptive formulations on carbohydrate and lipid metabolism. Lancet (1979) 2.08
Insulin resistance and cigarette smoking. Lancet (1992) 1.98
Divergent thinking: strategies and executive involvement in generating novel uses for familiar objects. Br J Psychol (2007) 1.75
A common DNA polymorphism of the low-density lipoprotein (LDL) receptor gene and its use in diagnosis. Lancet (1985) 1.64
Transport kinetics of plasma free fatty acid, very low density lipoprotein triglycerides and apoprotein in patients with endogenous hypertriglyceridaemia: effects of 2,2-dimethyl, 5(2, 5-xylyoxy) valeric acid therapy. Atherosclerosis (1976) 1.58
Role of insulin resistance in adipose tissue and liver in the pathogenesis of endogenous hypertriglyceridaemia in man. Diabetologia (1976) 1.52
Counting on working memory in arithmetic problem solving. Mem Cognit (1994) 1.51
Some effects of oral contraceptives on carbohydrate metabolism. Lancet (1969) 1.49
A fundamental defect of adrenocortical control in Cushing's disease. J Endocrinol (1968) 1.46
Sex hormone binding globulin capacity as an index of oestrogenicity or androgenicity in women on oral contraceptive steroids. Clin Endocrinol (Oxf) (1979) 1.46
The anabolic steroids. Practitioner (1968) 1.39
Vitamins and oral contraceptive use. Lancet (1975) 1.35
Sex, plasma lipoproteins, and atherosclerosis: prevailing assumptions and outstanding questions. Am Heart J (1987) 1.33
Apolipoprotein B gene variants are involved in the determination of serum cholesterol levels: a study in normo- and hyperlipidaemic individuals. Atherosclerosis (1987) 1.32
Serum-lipids in women on oral contraceptives. Lancet (1971) 1.29
The effect of progestins in combined oral contraceptives on serum lipids with special reference to high-density lipoproteins. Am J Obstet Gynecol (1982) 1.27
Endocrine function in patients with untreated chromophobe adenomas. Q J Med (1967) 1.13
Comparison of haematological indices between women of four ethnic groups and the effect of oral contraceptives. J Clin Pathol (1983) 1.09
Identification of a deletion in the low density lipoprotein (LDL) receptor gene in a patient with familial hypercholesterolaemia. Hum Genet (1985) 1.08
The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism. N Engl J Med (1990) 1.08
Effect of duration of low-dose oral contraceptive administration on carbohydrate metabolism. Am J Obstet Gynecol (1982) 1.05
The effects of the menopause on insulin sensitivity, secretion and elimination in non-obese, healthy women. Eur J Clin Invest (1993) 1.05
Visual similarity effects in immediate verbal serial recall. Q J Exp Psychol A (2000) 1.04
Effects of obesity, glucocorticoid, and oral contraceptive therapy on plasma glucose and blood pyruvate levels. Br Med J (1970) 1.02
Working memory and strategies in syllogistic-reasoning tasks. Mem Cognit (1993) 1.01
The kinetics of plasma free fatty acid and triglyceride transport in patients with idiopathic hypertriglyceridaemia and their relation to carbohydrate metabolism. Eur J Clin Invest (1974) 1.01
Mechanism of hypertriglyceridaemia associated with contraceptive steroids. Horm Metab Res (1973) 1.01
Comparison of transdermal and oral estrogen-progestin replacement therapy: effects on serum lipids and lipoproteins. Am J Obstet Gynecol (1992) 1.00
The role of memory in the Tower of London task. Memory (1999) 1.00
Plasma free fatty acid and triglyceride transport kinetics in man. Clin Sci Mol Med (1974) 0.99
Reproducibility of oral glucose tolerance data in normal and mildly diabetic subjects. Clin Endocrinol (Oxf) (1973) 0.99
Blood pyruvate and plasma glucose levels during oral and intravenous glucose tolerance tests in obese and non-obese women. Metabolism (1968) 0.98
Insulin resistance, secretion, and elimination in postmenopausal women receiving oral or transdermal hormone replacement therapy. Metabolism (1993) 0.98
Effect of pyridoxine hydrochloride (vitamin B 6 ) upon depression associated with oral contraception. Lancet (1973) 0.98
Insulin resistance, secretion, and metabolism in users of oral contraceptives. J Clin Endocrinol Metab (1992) 0.97
Metabolic effects of danazol. J Int Med Res (1977) 0.96
Dominant visible and electrophoretically expressed mutations induced in male mice exposed to ethylene oxide by inhalation. Environ Mutagen (1986) 0.95
Serum iron levels and response to hepatitis B virus. Proc Natl Acad Sci U S A (1979) 0.95
Group aggregates and individual reliability: the case of verbal short-term memory. Mem Cognit (1996) 0.95
Fasting serum triglyceride, cholesterol, and lipoprotein levels during oral-contraceptive therapy. Lancet (1969) 0.93
Autonomic and electrophysiological studies in patients with signs or symptoms of diabetic neuropathy. Electroencephalogr Clin Neurophysiol (1986) 0.93
Oral and intravenous suppression tests in the diagnosis of Cushing's syndrome. J Endocrinol (1965) 0.93
The evaluation of sodium valproate in the treatment of Nelson's syndrome. J Clin Endocrinol Metab (1983) 0.93
Metabolic effects of anabolic steroids. Br J Sports Med (1975) 0.91
Renin, angiotensin, corticosteroids, and electrolyte balance in Addison's disease. Q J Med (1968) 0.90
Parenteral administration of 6-alpha-methylprednisolone-21-acetate. II. Absorption and duration of effect. Ann Phys Med (1967) 0.90
Associations between insulin sensitivity, and free fatty acid and triglyceride metabolism independent of uncomplicated obesity. Metabolism (1994) 0.90
Variation in serum lipid and lipoprotein levels associated with changes in smoking behaviour in non-obese Caucasian males. Atherosclerosis (1985) 0.90
Effect of body mass index and fat distribution on insulin sensitivity, secretion, and clearance in nonobese healthy men. J Clin Endocrinol Metab (1992) 0.87
Inter-relationship between insulin secretion and plasma free fatty acid and triglyceride transport kinetics in maturity onset diabetes and the effect of phenethylbiguanide (phenformin). Diabetologia (1974) 0.87
Effects of oral and intravenous glucose loading in thyrotoxicosis. Studies of plasma glucose, free fatty acid, plasma insulin and blood pyruvate levels. Diabetes (1969) 0.87
Mechanism of oestrogen and progesterone effects on lipid and carbohydrate metabolism: alteration in the insulin: glucagon molar ratio and hepatic enzyme activity. Eur J Clin Invest (1977) 0.87
The assessment of hypothalamic-pituitary-adrenocortical function in man. Proc R Soc Med (1967) 0.86
Diurnal variation on oral glucose tolerance: insulin and growth hormone changes with special reference to women taking oral contraceptives. Diabetologia (1973) 0.86
Effect of posture on the plasma cholesterol level. Br Med J (1966) 0.86
The mechanism of action of clofibrate and tetranicotinoylfructose (Bradilan) on the kinetics of plasma free fatty acid and triglyceride transport in type IV and type V hypertriglyceridaemia. Eur J Clin Invest (1974) 0.85
Clofibrate and hyperlipidaemia. Lancet (1980) 0.85
The metabolic fate of plasma lipoproteins in normal subjects and in patients with insulin resistance and endogenous hypertriglyceridaemia. Diabetologia (1976) 0.85
Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease. Contraception (1995) 0.84
The influence on oral contraceptive formulation on carbohydrate and lipid metabolism. J Pharmacother (1980) 0.83
The role of calcium in insulin action. V. Importance of cyclic guanosine 3':5' monophosphate and calcium ions in insulin stimulation of lipoprotein lipase activity and protein synthesis in adipose tissue. Horm Metab Res (1978) 0.83
The effect of cholestyramine on the faecal excretion of bile acids and neutral steroids in familial hypercholesterolaemia. Atherosclerosis (1977) 0.83
Partial capitation versus fee-for-service in mental health care. Health Aff (Millwood) (1995) 0.82
SARS Surveillance Project--Internet-enabled multiregion surveillance for rapidly emerging disease. MMWR Morb Mortal Wkly Rep (2004) 0.82
Letter: The treatment of the problem patient with tuberculosis. Am Rev Respir Dis (1976) 0.82
Renal cortical Na+-K+-ATPase activity and abundance is decreased in normal pregnant rats. Am J Physiol (1998) 0.82
Evaluation of four mathematical models of glucose and insulin dynamics with analysis of effects of age and obesity. Am J Physiol (1992) 0.81
Influence of insulin resistance, secretion, and clearance on serum cholesterol, triglycerides, lipoprotein cholesterol, and blood pressure in healthy men. Arterioscler Thromb (1992) 0.81
The effects of cyproterone acetate and ethinyl oestradiol on carbohydrate metabolism. Clin Endocrinol (Oxf) (1984) 0.81
Effects of oral contraceptives on carbohydrate metabolism. J Reprod Med (1986) 0.81
Studies of carbohydrate and lipid metabolism in women developing hypertension on oral contraceptives. Br Med J (1973) 0.81
Pancreatic islet cell tumour with watery diarrhoea and hypokalaemia. Gut (1970) 0.80
Coronary heart disease risk markers in users of low-dose oral contraceptives. J Reprod Med (1991) 0.80
Late acute rejection occurring in liver allograft recipients. Can J Gastroenterol (1996) 0.80
Lipid and carbohydrate metabolic risk markers for coronary heart disease and blood pressure in healthy non-obese premenopausal women of different racial origins in the United Kingdom. Metabolism (1996) 0.80
Blood pyruvate and lactate levels during oral and intravenous glucose tolerance tests in diabetes mellitus. Clin Sci (1970) 0.80
Lipoprotein analyses in varying degrees of glucose tolerance. Comparison between non-insulin-dependent diabetic, impaired glucose tolerant, and control populations. Am J Med (1987) 0.80
Lipid and carbohydrate metabolism in premenopausal women given subdermal estradiol implants. Horm Metab Res (1991) 0.79
The effects of growth hormone on plasma glucose, NEFA, insulin and blood pyruvate levels during intravenous glucose tolerance tests. J Endocrinol (1969) 0.79
Physiological hyperinsulinemia is not associated with alterations in venous plasma levels of endothelin-1 in healthy individuals. Metabolism (1997) 0.79
Effect of treatment with sodium valproate and diazepam on plasma corticotropin in Nelson's syndrome. Lancet (1981) 0.78
Inverse relationship between serum Lp(a) levels and first-phase insulin secretion. Diabetes (1992) 0.78
The treatment of a hyperandrogenic and virilizing state in an elderly female with a synthetic LHRH agonist. J Endocrinol Invest (1988) 0.78
Oral contraceptives and coronary heart disease: modulation of glucose tolerance and plasma lipid risk factors by progestins. Am J Obstet Gynecol (1988) 0.78
Effects of a low-estrogen, desogestrel-containing oral contraceptive on lipid and carbohydrate metabolism. Contraception (1993) 0.78
Influence of oral contraceptives, pyridoxine (vitamin B6), and tryptophan on carbohydrate metabolism. Lancet (1976) 0.77
Effect of methandienone on free fatty acid and triglyceride turnover in normal females. Horm Metab Res (1973) 0.77
Corticotrophin, cortisol, prolactin and growth hormone responses to insulin-induced hypoglycaemia in normal subjects given sodium valproate. Clin Endocrinol (Oxf) (1985) 0.77
Insulin action and dynamics modelled in patients taking the anabolic steroid methandienone (Dianabol). Clin Sci (Lond) (1986) 0.77
Analysis of high density lipoprotein subclasses by a precipitation procedure: comparison with preparative ultracentrifuge. Clin Chim Acta (1982) 0.77
The effects of reverse sequential anti-androgen therapy (cyproterone acetate and ethinyl estradiol) on hematological parameters. J Endocrinol Invest (1987) 0.76
Clinical and metabolic considerations of long-term oral contraceptive use. Am J Obstet Gynecol (1992) 0.76
Rising cholesterol levels in children with familial hypercholesterolaemia. Biomed Pharmacother (1990) 0.76